Another noteworthy application of sodium thiocyanate is in the field of pharmaceuticals. It has been investigated for its potential therapeutic uses, particularly in treating conditions related to thyroid function. Thiocyanate ions are known to inhibit the uptake of iodine by the thyroid gland, which can be beneficial in managing hyperthyroid conditions. However, the use of sodium thiocyanate in medicine requires careful dosing and monitoring, given its potential side effects and toxicology.
LOLA assists in this metabolic process by promoting the conversion of ammonia into non-toxic substances. The dipeptide acts as a substrate for the synthesis of urea, thereby enhancing the ammonia detoxification pathway. Clinical studies have demonstrated that LOLA can significantly reduce ammonia levels in patients, consequently alleviating symptoms associated with hepatic encephalopathy, such as confusion, altered consciousness, and even coma.